Navigation Links
Elsevier organizes label-free technologies conference
Date:4/5/2012

Oxford, April 5, 2012 Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces the Label-Free Technologies Conference to be held in Amsterdam, the Netherlands, 1-3 November 2012.

Organized by Elsevier in association with Horiba Scientific, Label-Free Technologies will be a two-day conference entirely dedicated to bringing together the latest research on the advances and application of label-free technology in pharmacology and drug discovery.

The conference, chaired by Professor Evi Kostenis, University of Bonn, Germany and Professor Anthony (Tony) Turner, Linkping University, Sweden, will focus on three themes; state of the art, new applications of currently available instruments and emerging technologies.

"Label-free technologies have made enormous progress in recent years and have generated wealth well beyond the simple sales figures associated with the instruments themselves, by enabling drug development and research in the life sciences. It is now timely to review this emerging subject area and to consolidate the advanced applications now available while looking to the future for what will become available," said conference Co-Chair Professor Turner.

Elsevier's journals Drug Discovery Today and Biosensors & Bioelectronics are the supporting publications for the conference.

Abstracts for oral and poster presentations are invited.

More information including invited speakers available at: http://www.labelfreetech.com


'/>"/>

Contact: Irene Kanter-Schlifke
I.Kanter@elsevier.com
31-204-853-359
Elsevier
Source:Eurekalert

Page: 1

Related medicine news :

1. Elseviers new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content
2. Elseviers Journal of Evidence-Based Dental Practice celebrates 10th year with special issue
3. Elsevier launches Carpentiers reconstructive valve surgery book
4. Elsevier introduces Cardiac Electrophysiology Clinics
5. Elsevier and InfoDesk collaborate to co-develop federated drug pipeline intelligence solution
6. Elsevier acquires Collexis
7. Elsevier and International Society of Geriatric Oncology launch Journal of Geriatric Oncology
8. Elsevier partners with ASRT to provide multimedia educational modules through Mosbys Imaging Suite
9. Elsevier partners with Helinet to strengthen consortiums leadership in health sciences education
10. Gold Standard/Elsevier promotes medication safety and compliance via New MEDcounselor languages
11. Gold Standard/Elsevier first to launch state, federal controlled substance drug schedules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy ... health literacy software tool, and the Cancer Patient Education Network (CPEN), an independent ... today announce a new strategic alliance. , As CPEN’s strategic partner, HLI ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of California Berkeley, and other leading institutions in announcing the launch of the ... to change the way animals are raised for food. , Founding members of ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical , ... company with their  2017 New Product Innovation Award for ... extensive primary and secondary medical device market research by Frost ... its first-to-market OTC, drug-free pain relief product, the AVACEN 100, ... to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... , Oct. 11, 2017  True Health, ... has amplified its effort during National Breast Cancer ... hereditary cancer risks. ... Clinical Oncology calculated that more than 10 million ... inherited mutations in BRCA1 or BRCA2 and have not ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
Breaking Medicine Technology: